START FREE TRIAL

Salesforce Just Bought Momentum — But The REAL Play Is Workflow Control!

AI Summary

🔒 UNLOCK AI SUMMARY WITH FREE TRIAL

START FREE TRIAL

It has been a busy stretch for Salesforce (NYSE:CRM). Fresh off a strong fiscal third quarter, the company is leaning hard into its Agentforce vision while sharpening its data foundation through Informatica. Revenue hit $10.26 billion in Q3, operating margins expanded, and Agentforce ARR surged more than 300% year over year. Now comes another strategic step: a definitive agreement to acquire Momentum, a conversational insights and revenue orchestration platform. Momentum captures unstructured voice and video data from platforms like Zoom and Google Meet, then turns that data into structured insights. Salesforce plans to integrate that capability into Agentforce 360 and Slackbot. The deal is expected to close in the first quarter of fiscal 2027. On the surface, it looks like another bolt-on acquisition. Underneath, it could meaningfully deepen Salesforce’s AI moat.

Deeper Conversation Intelligence Across Voice & Video

Momentum’s core value is simple but powerful. It captures and analyzes customer conversations that happen outside traditional CRM workflows. Think Zoom calls, Google Meet sessions, and other video or voice platforms. Most of that data is…

Continue Reading With Our 7-Day Free Trial

ONLY $10 per month after the trial. Cancel anytime. No sponsors. No conflicts. 100% independent stock research.

Recent Articles

Meta’s AI Launch Looks Like Progress — But Something Feels Off

Meta Platforms (NASDAQ:META) just gave investors a fresh AI...

The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!

The market loves excitement. But money is often made...

Is Globalstar A Shortcut For Amazon—But A REAL Constraint For Apple?

When a stock jumps on takeover chatter, the easy...

Apple & The AI Supply Crunch — What Wall Street Is Missing!

Apple (NASDAQ:AAPL) is not the company most people think...

This Biotech Stock Already Has A Blockbuster; So Why Is It ACQUIRING Another Rare Disease Asset?

There are biotech stories that look obvious, and then...

Related Articles

Meta’s AI Launch Looks Like Progress — But Something Feels Off

Meta Platforms (NASDAQ:META) just gave investors a fresh AI...

The “Boring” Healthcare Stock Making A $5 Billion POWER MOVE!

The market loves excitement. But money is often made...

Is Globalstar A Shortcut For Amazon—But A REAL Constraint For Apple?

When a stock jumps on takeover chatter, the easy...

Apple & The AI Supply Crunch — What Wall Street Is Missing!

Apple (NASDAQ:AAPL) is not the company most people think...

This AI Infra Stock Could Anchor 6G And Edge Computing; PE Knows It’s MISPRICED!

There’s a reason SBA Communications (NASDAQ: SBAC) has suddenly...

Unilever’s $42 Billion Selloff Is Hiding a Much BIGGER Bet!

Unilever (NYSE: UL) did not just announce a deal—it...

Nike’s China Slump Is Starting to Look Like Something More!

Nike (NYSE:NKE) has spent years selling the idea that...
spot_img

Related Articles

Popular Categories

spot_imgspot_img